Figure 4.
Dose-related effects of "PKC-ι/λ inhibitor, ICAPP, on expression of lipogenic (SREBP-1c, FAS, ACC), inflammatory (TNF-α, ILl-1β) and glucogenic (PEPCK, G6Pase) enzymes in hepatocytes of non-diabetic humans. Incubation time, 4 hours with or without 1µmol/l insulin. Values are mean ± SEM of 4 or more determinations. Data are from cells used in the Fig 3.